Advanced Filters
noise
Found 1,216 clinical trials
N Noah Vieira

taVNS or TMS or Both for Depression

The purpose of the research is to test out a combined treatment for depression where the investigators stimulate a nerve in the ear while at the same time stimulate the brain with magnets. These treatments are called transcutaneous (through the skin) auricular (ear) vagus nerve stimulation (taVNS) and transcranial (through …

18 - 75 years of age All Phase N/A
N Nazanin Alavi, MD

Comparing Clinical Decision-making of AI Technology to a Multi-professional Care Team in ECBT for Depression

Depression is a leading cause of disability worldwide, affecting up to 300 million people globally. Despite its high prevalence and debilitating effects, only one-third of patients newly diagnosed with depression initiate treatment. Electronic cognitive behavioural therapy (e-CBT) is an effective treatment for depression and is a feasible solution to make …

18 years of age All Phase N/A
C Chai Nien Foo

Biomarkers, TCM Body Constitution, Dietary Pattern and Psychological Factors in Predicting Depression

This study aims to determine the predictors of depression among university students in Universiti Tunku Abdul Rahman (UTAR) Sungai Long Campus.

18 - 30 years of age All Phase N/A

Brain Stimulation and Decision-making

Decision-making is an important process that is frequently shown to be impaired in patients with depression. While a number of preclinical and clinical studies have identified key regions involved in this process, it remains unclear exactly how these regions are influencing choice behavior especially when choices become more challenging. The …

18 - 50 years of age All Phase N/A
H Helene J Hopman, PhD

rTMS Response Trajectories in Depression

Notwithstanding the cumulative evidence on the safety and efficacy of transcranial magnetic stimulation in depression care, the non-response rate to transcranial magnetic stimulation (TMS) amongst treatment-resistant depression has remained substantial despite the health care cost and time incurred. There remains a compelling clinical need to find valid biomarkers to inform …

18 - 64 years of age All Phase N/A
T Teresa Victor, PhD

Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression

This study aims to determine whether a keto-like supplement relative to placebo results in functional brain changes during fMRI tasks evaluating positive and negative valence in individuals with moderate to severe depression. In this double-blind randomized placebo-controlled trial, 75 individuals with a Patient Health Questionnaire (PHQ-9) scale score ≥ 10 …

18 - 65 years of age All Phase 2
K Kate R Kuhlman

Positive Affect Treatment for Adolescents With Early Life Adversity

Youth exposed to early life adversity (ELA) are known to be at greater risk for depression and suicidality and account for almost half of the youth suffering from psychiatric diseases today. Youth exposed to ELA consistently report symptoms of anhedonia as well as dysregulated positive affect. The present project will …

12 - 16 years of age All Phase N/A
A Anne Sofie Kvist Houby, MD

The Advance Project - Advancing Sleep Timing to Improve Depression

150 patients with moderate to severe depression, recently discharged from a psychiatric ward and now recieving treatment at an outpatient unit at Mental Health Center Copenhagen, will be randomised in to two groups. A treatment ad usual (TAU) group and an Advance-group. The Advance-group will receive a psychotherapeutic intervention focusing …

18 years of age All Phase N/A
M Melker Hagsäter

VGR Accelerated TMS Treatment for Depression

Intermittent theta burst stimulation (iTBS), a variant of repetitive transcranial magnetic stimulation (rTMS), is a well documented method for treatment of depression. The aim of the study is to assess the effect of an accelerated iTBS protocol compared to a routine iTBS protocol. In the accelerated protocol patients will receive …

18 years of age All Phase N/A

Latino Teen Depression Treatment Study

Despite experiencing higher rates of depressive symptoms (Center for Disease Control and Prevention, 2020) and similar rates of Major Depressive Disorder (MDD; Substance Abuse and Mental Health Services Administration (SAMHSA), 2019), Latino adolescents in the U.S. are significantly less likely than their non-Latino White peers to receive treatment for MDD …

13 years of age All Phase N/A

Simplify language using AI